3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Breast Neoplasms
20
Neoplasms
17
Lung Neoplasms
11
Carcinoma, Non-Small-Cell Lung
9
Uterine Cervical Neoplasms
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Ovarian Neoplasms
4
Myelodysplastic Syndromes
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Carcinoma, Hepatocellular
4
Triple Negative Breast Neoplasms
3
Skin Neoplasms
3
Neoplasm Metastasis
3
Kidney Neoplasms
3
Carcinoma, Renal Cell
3
Uveal Melanoma
2
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lymphoma
2
Lung Diseases
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Interventions
Cyclophosphamide
15
venetoclax
11
fludarabine
10
Cytarabine
10
Mycophenolic Acid
6
Azacitidine
6
fludarabine phosphate
5
Daunorubicin
5
Busulfan
5
ruxolitinib
4
ponatinib
4
blinatumomab
4
Whole-Body Irradiation
4
Vincristine
4
Tacrolimus
4
Rituximab
4
Methotrexate
4
Dexamethasone
4
asciminib
3
Mercaptopurine
3
Inotuzumab Ozogamicin
3
Granulocyte Colony-Stimulating Factor
3
Cyclosporine
3
revumenib
2
quizartinib
2
pegaspargase
2
nilotinib
2
ibrutinib
2
Thioguanine
2
Prednisone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
Blood Specimen Collection
×
90 days
×
Clear all
NCT07249476
2026-04-29
ENKLA-M
Nantes University Hospital
Not yet recruiting
55 enrolled